Anthony Charles Bejjani

Title(s)Hs Assistant Clinical Professor, Medicine
SchoolMedicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Numerous gastric nodules in a leukaemia patient. Gut. 2024 01 05; 73(2):281-337. Bahdi F, Alkassis S, Lewis MS, El-Masry M, Bejjani A, Kolb JM. PMID: 36990679.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Evolution of Systemic Therapy in Advanced Hepatocellular Carcinoma. Surg Oncol Clin N Am. 2024 01; 33(1):73-85. Bejjani A, Finn RS. PMID: 37945146.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Very Unstable Genetics: How the Confluence of Microsatellite Instability and Immunotherapy Revolutionized the Treatment of Colon Cancer. Dig Dis Sci. 2023 09; 68(9):3494-3503. Kaunitz JD, Bejjani A. PMID: 37402981.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma. Gastroenterology. 2023 01; 164(1):72-88.e18. Haber PK, Castet F, Torres-Martin M, Andreu-Oller C, Puigvehí M, Miho M, Radu P, Dufour JF, Verslype C, Zimpel C, Marquardt JU, Galle PR, Vogel A, Bathon M, Meyer T, Labgaa I, Digklia A, Roberts LR, Mohamed Ali MA, Mínguez B, Citterio D, Mazzaferro V, Finkelmeier F, Trojan J, Özdirik B, Müller T, Schmelzle M, Bejjani A, Sung MW, Schwartz ME, Finn RS, Thung S, Villanueva A, Sia D, Llovet JM. PMID: 36108710.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    5. Hepatocellular Carcinoma: Pick the Winner-Tyrosine Kinase Inhibitor Versus Immuno-oncology Agent-Based Combinations. J Clin Oncol. 2022 08 20; 40(24):2763-2773. Bejjani AC, Finn RS. PMID: 35649192.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    6. Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study. JMIR Cancer. 2022 05 19; 8(2):e33859. Kalra M, Henry E, McCann K, Karuturi MS, Bustamante Alvarez JG, Parkes A, Wesolowski R, Wei M, Mougalian SS, Durm G, Qin A, Schonewolf C, Trivedi M, Armaghani AJ, Wilson FH, Iams WT, Turk AA, Vikas P, Cecchini M, Lubner S, Pathak P, Spencer K, Koshkin VS, Labriola MK, Marshall CH, Beckermann KE, theMednet.org NCI-CCC Tumor Board Program Collaborative Group, Sharifi MN, Bejjani AC, Hotchandani V, Housri S, Housri N. PMID: 35588361; PMCID: PMC9164098.
      View in: PubMed   Mentions:
    7. Using a Collaborative, Virtual Discussion Platform to Mobilize Oncologic Expertise for the COVID-19 Pandemic. JCO Clin Cancer Inform. 2020 09; 4:794-798. Bejjani A, Burt L, Washington C, Terao M, Housri S, Housri N. PMID: 32897736; PMCID: PMC7529517.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsPHPublic Health
    8. Systemic Therapy for Primary Liver Tumors: Cholangiocarcinoma and Hepatocellular Carcinoma. Surg Oncol Clin N Am. 2019 10; 28(4):695-715. Sadeghi S, Bejjani A, Finn RS. PMID: 31472914.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    9. The Place of Novel Therapies in the American Association for the Study of Liver Diseases Guidelines for Hepatocellular Carcinoma. Clin Liver Dis (Hoboken). 2019 Aug; 14(2):51-55. Bejjani A, Finn RS. PMID: 31508220; PMCID: PMC6726383.
      View in: PubMed   Mentions: 3  
    10. B-cell acute lymphoblastic leukemia as a secondary malignancy following diffuse large B-cell lymphoma. Hematol Rep. 2019 May 23; 11(2):8100. Gaut D, Bejjani A, Sasine J, Schiller G. PMID: 31285810; PMCID: PMC6589539.
      View in: PubMed   Mentions:
    11. Hepatic Abscess in a Returning Traveler with Crohn's Disease: Differentiating Amebic from Pyogenic Liver Abscess. Case Rep Med. 2018; 2018:9593865. Gaut D, Shull H, Bejjani A, Kahn D. PMID: 30002680; PMCID: PMC5996425.
      View in: PubMed   Mentions: 3  
    12. 1H MRSI of middle frontal gyrus in pediatric ADHD. J Psychiatr Res. 2013 Apr; 47(4):505-12. Tafazoli S, O'Neill J, Bejjani A, Ly R, Salamon N, McCracken JT, Alger JR, Levitt JG. PMID: 23273650; PMCID: PMC3609653.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    13. Elevated glutamatergic compounds in pregenual anterior cingulate in pediatric autism spectrum disorder demonstrated by 1H MRS and 1H MRSI. PLoS One. 2012; 7(7):e38786. Bejjani A, O'Neill J, Kim JA, Frew AJ, Yee VW, Ly R, Kitchen C, Salamon N, McCracken JT, Toga AW, Alger JR, Levitt JG. PMID: 22848344; PMCID: PMC3407186.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCTClinical Trials
    Anthony's Networks
    Concepts (54)
    Derived automatically from this person's publications.
    _
    Co-Authors (9)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _